Your browser doesn't support javascript.
loading
Diabetic Foot Osteomyelitis in Patients with and without Peripheral Arterial Disease: Two Different Diseases?
Meloni, Marco; Bellizzi, Ermanno; Andreadi, Aikaterini; Di Venanzio, Michela; Mazzeo, Luca; Giurato, Laura; Bellia, Alfonso; Uccioli, Luigi; Lauro, Davide.
Afiliação
  • Meloni M; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Bellizzi E; University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.
  • Andreadi A; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Di Venanzio M; University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.
  • Mazzeo L; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Giurato L; University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.
  • Bellia A; Studio Podologico Di Venanzio, Rieti, Italy.
  • Uccioli L; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Lauro D; University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.
Int J Low Extrem Wounds ; : 15347346241264383, 2024 Jul 21.
Article em En | MEDLINE | ID: mdl-39034155
ABSTRACT
The aim of the current study was to evaluate the outcomes of patients with diabetic foot osteomyelitis (DFO), comparing subjects with and without peripheral arterial disease (PAD). The study is a prospective study including a population of patients affected by a DFO located in the forefoot. All patients were managed by a surgical conservative approach defined by the removal of the infected bone, in association with the antibiotic therapy. Patients were divided into two groups those with PAD (neuro-ischaemic DFO) and those without (neuropathic DFO). After 1 year of follow-up, the following outcome were evaluated and compared between groups healing, healing time, minor amputation, major amputation, hospitalization, need for surgical re-intervention. Overall, 166 patients were included, 87(52.4%) of them had neuro-ischaemic DFO and 79 (47.6%) neuropathic DFO. Patients with neuro-ischaemic DFO in comparison to neuropathic DFO were older (72.5 ± 9 vs 64.1 ± 15.5 years, P < .0001), had longer diabetes duration (21.8 ± 5.6 vs 16.4 ± 7.6 years, P < .0001), higher rate of dialysis (13.8 vs 1.3%, P = .001) and ischaemic heart disease (79.3 vs 12.7%, P < .0001). Outcomes for neuro-ischaemic DFO and neuropathic DFO were healing (96.5 vs 97.5%, P = .7), healing time (7.8 ± 6.2 vs 5.7 ± 3.7 weeks, P = .01), minor amputation (16.1 vs 3.8%, P = .006), major amputation (0 vs 0%, ns), hospitalization (90.8 vs 51.9%, P < .0001), surgical re-intervention (14.9 vs 8.8%, P = .004) respectively. In addition, PAD resulted in an independent predictor of minor amputation, hospitalization, and surgical re-intervention. DFO in patients with PAD was characterized by longer healing time, more cases of minor amputation, hospitalization, and surgical re-intervention. PAD independently predicted the risk of minor amputation, hospitalization, and surgical re-intervention, while it was not associated with the healing rate.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Int J Low Extrem Wounds Assunto da revista: TRAUMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Int J Low Extrem Wounds Assunto da revista: TRAUMATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália